BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 28445690)

  • 1. Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis.
    Więdłocha M; Marcinowicz P; Krupa R; Janoska-Jaździk M; Janus M; Dębowska W; Mosiołek A; Waszkiewicz N; Szulc A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):217-226. PubMed ID: 28445690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
    Hannestad J; DellaGioia N; Bloch M
    Neuropsychopharmacology; 2011 Nov; 36(12):2452-9. PubMed ID: 21796103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.
    Liu JJ; Wei YB; Strawbridge R; Bao Y; Chang S; Shi L; Que J; Gadad BS; Trivedi MH; Kelsoe JR; Lu L
    Mol Psychiatry; 2020 Feb; 25(2):339-350. PubMed ID: 31427752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression.
    Schmidt FM; Schröder T; Kirkby KC; Sander C; Suslow T; Holdt LM; Teupser D; Hegerl U; Himmerich H
    Psychiatry Res; 2016 May; 239():85-91. PubMed ID: 27137966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression.
    Zou W; Feng R; Yang Y
    PLoS One; 2018; 13(6):e0197267. PubMed ID: 29856741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
    Köhler CA; Freitas TH; Stubbs B; Maes M; Solmi M; Veronese N; de Andrade NQ; Morris G; Fernandes BS; Brunoni AR; Herrmann N; Raison CL; Miller BJ; Lanctôt KL; Carvalho AF
    Mol Neurobiol; 2018 May; 55(5):4195-4206. PubMed ID: 28612257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds.
    Fornaro M; Rocchi G; Escelsior A; Contini P; Martino M
    J Affect Disord; 2013 Mar; 145(3):300-7. PubMed ID: 22981313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis.
    Wang L; Wang R; Liu L; Qiao D; Baldwin DS; Hou R
    Brain Behav Immun; 2019 Jul; 79():24-38. PubMed ID: 30797959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery.
    Dahl J; Ormstad H; Aass HC; Malt UF; Bendz LT; Sandvik L; Brundin L; Andreassen OA
    Psychoneuroendocrinology; 2014 Jul; 45():77-86. PubMed ID: 24845179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
    Park M; Newman LE; Gold PW; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
    J Psychiatr Res; 2017 Jan; 84():113-118. PubMed ID: 27718369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the relationship between proinflammatory cytokines and major depressive disorder.
    Young JJ; Bruno D; Pomara N
    J Affect Disord; 2014 Dec; 169():15-20. PubMed ID: 25128861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder.
    Alcocer-Gómez E; Casas-Barquero N; Williams MR; Romero-Guillena SL; Cañadas-Lozano D; Bullón P; Sánchez-Alcazar JA; Navarro-Pando JM; Cordero MD
    Pharmacol Res; 2017 Jul; 121():114-121. PubMed ID: 28465217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connection between inflammatory markers, antidepressants and depression.
    Crnković D; Buljan D; Karlović D; Krmek M
    Acta Clin Croat; 2012 Mar; 51(1):25-33. PubMed ID: 22919999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.
    Rethorst CD; Toups MS; Greer TL; Nakonezny PA; Carmody TJ; Grannemann BD; Huebinger RM; Barber RC; Trivedi MH
    Mol Psychiatry; 2013 Oct; 18(10):1119-24. PubMed ID: 22925832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antidepressant drug therapy with or without physical exercise on inflammatory biomarkers in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.
    Fernandes BM; Scotti-Muzzi E; Soeiro-de-Souza MG
    Eur J Clin Pharmacol; 2022 Mar; 78(3):339-349. PubMed ID: 34708271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation.
    Vogelzangs N; Duivis HE; Beekman AT; Kluft C; Neuteboom J; Hoogendijk W; Smit JH; de Jonge P; Penninx BW
    Transl Psychiatry; 2012 Feb; 2(2):e79. PubMed ID: 22832816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disorders.
    Sun Y; Narayan VA; Wittenberg GM
    BMC Pharmacol Toxicol; 2016 Oct; 17(1):47. PubMed ID: 27765060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A shift toward T helper 2 responses and an increase in modulators of innate immunity in depressed patients treated with escitalopram.
    Ho PS; Yeh YW; Huang SY; Liang CS
    Psychoneuroendocrinology; 2015 Mar; 53():246-55. PubMed ID: 25647343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels.
    Dahl J; Ormstad H; Aass HC; Sandvik L; Malt UF; Andreassen OA
    Acta Psychiatr Scand; 2016 Jul; 134(1):40-7. PubMed ID: 27028967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Indoleamine-2,3-Dioxygenase (IDO) is Increased in Drug-Naï ve Major Depressed Patients and Treatment with Sertraline and Ketoprofen Normalizes IDO in Association with Pro-Inflammatory and Immune- Regulatory Cytokines.
    Al-Hakeim HK; Twayej AJ; Al-Dujaili AH; Maes M
    CNS Neurol Disord Drug Targets; 2020; 19(1):44-54. PubMed ID: 31894751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.